Hummsa Biotech (Backed by 100X.VC)

At Hummsa Biotech, we are pioneering a transformative theranostic approach by harnessing the power of synthetic biology. Our cutting-edge platform is designed to replace traditional antibodies in both therapeutic and diagnostic applications, setting new standards in precision medicine. Traditional antibodies, while groundbreaking in their time, come with limitations such as variability, long development times, and stability issues. Our patented synthetic biology-enabled technology overcomes these challenges, offering superior specificity, stability, and rapid development capabilities. By integrating innovative & novel nanotechnology, we develop nanosensors for highly sensitive diagnostics and nanobodies for precise, targeted therapeutics. This unique combination allows us to create solutions that are not only more effective but also adaptable to a wide range of medical challenges. Our mission is to revolutionize healthcare by providing advanced, reliable, and scalable solutions that address the complexities of modern medicine. Hummsa Biotech represents the future of diagnostics and therapeutics, driving innovation forward with a touch of mystery that inspires and excites. Join us on our journey as we redefine what's possible in healthcare.

Website

www.hummsabiotech.com

External link for Hummsa Biotech (Backed by 100X.VC)

Industry

Biotechnology Research

Company size

2-10 employees

Type

Privately Held